Long‐term follow‐up of patients with intermediate‐risk neuroblastoma treated with response‐ and biology‐based therapy: A report from the Children's Oncology Group study ANBL0531.

Bibliographic Details
Title: Long‐term follow‐up of patients with intermediate‐risk neuroblastoma treated with response‐ and biology‐based therapy: A report from the Children's Oncology Group study ANBL0531.
Authors: Barr, Erin K., Naranjo, Arlene, Twist, Clare J., Tenney, Sheena C., Schmidt, Mary Lou, London, Wendy B., Gastier‐Foster, Julie, Adkins, E. Stanton, Mattei, Peter, Handler, Michael H., Matthay, Katherine K., Park, Julie R., Maris, John M., Desai, Ami V., Cohn, Susan L.
Source: Pediatric Blood & Cancer; Aug2024, Vol. 71 Issue 8, p1-11, 11p
Database: Complementary Index
More Details
ISSN:15455009
DOI:10.1002/pbc.31089
Published in:Pediatric Blood & Cancer
Language:English